Transforming Enterprise Procurement: Phanindra Kankanampati's Cross-Industry Impact
A distinguished technology leader, Phanindra Kankanampati has established himself as an expert in procurement technology and ...
Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘This Company Has Never Lost Its Ability To Develop New Medicines’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...
pharmaphorum22h
AZ, Amgen get speedy FDA review for asthma drug tezepelumab
AZ and Amgen tried and failed to develop tezepelumab as a therapy for atopic dermatitis, chalking up one failed phase 3 trial in 2017, but have continued to develop the drug for other indications ...